Voloridge Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-53,208
Closed -$2.24M 1662
2023
Q2
$2.24M Sell
53,208
-365,102
-87% -$14.8M 0.01% 949
2023
Q1
$14.9M Sell
418,310
-164,633
-28% -$5.97M 0.07% 353
2022
Q4
$21.4M Buy
582,943
+521,365
+847% +$20.6M 0.12% 248
2022
Q3
$2.9M Buy
+61,578
New +$3.98M 0.02% 858
2021
Q3
Sell
-32,965
Closed -$2.95M 1937
2021
Q2
$2.95M Buy
32,965
+29,873
+966% +$2.52M 0.02% 840
2021
Q1
$235K Buy
+3,092
New +$233K ﹤0.01% 1293
2020
Q1
Sell
-47,543
Closed -$2.83M 1480
2019
Q4
$2.83M Buy
+47,543
New +$2.56M 0.06% 409
2017
Q3
Sell
-136,776
Closed -$8M 565
2017
Q2
$8M Buy
+136,776
New +$7.11M 0.2% 131

Other funds holding SYNH

Voloridge Investment Management's SYNH Position: Q3 2023 in Review

Voloridge Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 53,208 shares — an estimated $2.24M sold.

Voloridge Investment Management first reported a position in SYNH in Q2 2017 and held it in 8 quarters. The position peaked at $21.4M in Q4 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Voloridge Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 53,208 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.24M.
  • Voloridge Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2017 and held it in 8 quarters.
  • Voloridge Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $21.4M in Q4 2022.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Voloridge Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.